FIELD: medicine; oncology.
SUBSTANCE: offered solid pharmaceutical compositions contain immunomodulatory compound namely 3-(4-amino-1-oxo-1,3-dihydroisoindole-2-yl)piperidine-2,6-dion. Compositions are characterised by varied modifications of crystal lattice of the given immunomodulatory compound.
EFFECT: stability of crystal condition of immunomodulator contained in pharmaceutical compositions within production and storage of medicinal forms along with good solubility in aqueous environment.
34 cl, 2 tbl, 1 dwg
| Title |
Year |
Author |
Number |
| METHODS AND COMPOSITIONS WITH APPLICATION OF IMMUNOMODELLING COMPOUNDS IN COMBINED TREATMENT |
2007 |
- Verell' Dominik
- Chan' Kajl
- Korral Lora
- Mutu De Parseval' Lor
- Brehdi Khelen
|
RU2426542C2 |
| ISOINDOLINE COMPOUNDS USED FOR TREATING CANCER |
2009 |
- Mjuller Dzhordzh V.
- Rachelmen Aleksander L.
|
RU2527952C2 |
| USE OF 3-(4-AMINO-1-OXO-1, 3-DIHYDROISOINDOL-2-YL)PIPERIDINE-2,6-DIONE FOR TREATING MANTLE CELL LYMPHOMAS |
2007 |
|
RU2446804C2 |
| METHODS FOR ADMINISTRATION OF 3-(4-AMINO-1-OXO-1,3-DIHYDROISOINDOLE-2-YL)PIPERIDINE-2,6-DIONE IN CERTAIN TYPES OF LEUKEMIA |
2006 |
|
RU2406501C2 |
| 5-SUBSTITUTED ISOINDOLINE COMPOUNDS |
2007 |
- Mjuller Dzhordzh V.
- Chehn' Rodzher S.K.
- Rachelmen Aleksander L.
|
RU2448101C2 |
| IMIDE MODULATORS OF PROTEOLYSIS AND METHODS FOR USING THEM |
2015 |
- Kruz Krejg
- Kryu Endryu P.
- Dun Khantsin
- Van Tszin
- Tsian Imin
- Tszin Mejchzhun
|
RU2738833C2 |
| PHTHALIMIDO-DERIVATIVES AS MONOAMINE OXIDASE B INHIBITORS |
2003 |
- Tsezura Andrea
- Rodriges-Sarm'Ento Rosa-Marija
- Tomas Ehndr'Ju Uill'Jams
- Viler Rene
|
RU2317289C2 |
| IMIDES BASED PROTEOLYSIS MODULATORS AND RELATED METHODS OF USE |
2016 |
- Crews, Craig, M.
- Crew, Andrew, P.
- Dong, Hanqing
- Wang, Jing
- Qian, Yimin
- Siu, Kam
- Jin, Meizhong
|
RU2704807C2 |
| DERIVATIVES OF 5-SUBSTITUTED QUINAZOLINONE, COMPOSITIONS CONTAINING THEM AND METHODS OF APPLICATION THEREOF |
2012 |
- Myuller Dzhordzh V.
- Men Khon-Va
|
RU2617989C2 |
| 2,6-DIOXOPIPERIDINE, METHOD FOR REDUCTION OF UNDESIRABLE LEVELS OF TNF-ALPHA IN MAMMAL, PHARMACEUTICAL COMPOSITION |
1998 |
- Maller Dzhordzh U.
- Sterling Dejvid I.
- Chen Rodzher Shen-Chu
|
RU2209207C2 |
